TRUVADA
- Product NDC
- 61919-669
- 11-digit product format
- 619190669
- Labeler code
- 61919
- Product ID
- 61919-669_9cad6d5a-7951-9080-e053-2a95a90a9281
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- emtricitabine and tenofovir disoproxil fumarate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- NDA021752
- Marketing category
- NDA
- Marketing start
- 2017-02-22
- Marketing end
- 0000-00-00
- Substance
- EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- Active strength
- 200 mg/1; mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-669-02 | 61919066902 | 2 TABLET, FILM COATED in 1 BOTTLE (61919-669-02) | 2017-02-22 | 0000-00-00 | No | No | Current |